Polycystic Ovary Syndrome
Conditions
Interventions
Non-Phlegm-Dampness Type PCOS-NIR:Collect and Store Blood Samples
Healthy population:Collect and Store Blood Samples
Phlegm-Dampness Type PCOS-IR:Collect and Store Blood Samples
Sponsors
The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Inclusion Criteria for Phlegm-Dampness Type PCOS-IR (1) Age between 18 and 45 years old; (2) Meet the diagnostic criteria for PCOS-IR in Western medicine and also meet the criteria for phlegm-dampness syndrome in Traditional Chinese Medicine (TCM); (3) Have not taken any medications that affect sex hormones within the past three months; (4) Willing to sign the informed consent form. 2. Inclusion Criteria for Non-Phlegm-Dampness Type PCOS-NIR (1) Age between 18 and 45 years old; (2) Meet the diagnostic criteria for PCOS-IR in Western medicine but do not meet the criteria for phlegm-dampness syndrome in Traditional Chinese Medicine (TCM); (3) Have not taken any medications that affect sex hormones within the past three months; (4) Willing to sign the informed consent form. 3. Inclusion Criteria for Control Group (1) Age between 18 and 45 years old; (2) Confirmed through health check-ups to have no severe organic or functional diseases; (3) Do not have PCOS or IR; (4) Willing to participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Other diseases that cause ovulatory dysfunction (including thyroid dysfunction premature ovarian failure hypothalamic-pituitary amenorrhea hyperprolactinemia etc.) and diseases that cause hyperandrogenemia (including Cushing's syndrome non-classic congenital adrenal hyperplasia androgen-secreting endocrine tumors etc.); (2) Patients with severe cardiovascular and cerebrovascular diseases liver kidney or hematopoietic system diseases malignancies or psychiatric disorders; (3) Those who have taken hormonal medications (except progesterone) or metformin within the past three months that may affect the results; (4) Individuals currently participating in other clinical studies or planning to become pregnant within the next three months. Any individual meeting one or more of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differentially Expressed Proteins; | — |
Countries
China
Contacts
Public ContactWei Chen
The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Outcome results
None listed